Aristo Bio-Tech and Lifescience (NSE:ARISTO) DeferredTaxAndRevenue: ₹0 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ARISTO Aristo Bio-Tech and Lifescience Ltd NSE:ARISTO
59 GF Score
Price ₹109.30
View Full Analysis

What is Aristo Bio-Tech and Lifescience DeferredTaxAndRevenue?

Aristo Bio-Tech and Lifescience NSE:ARISTO +0.05% 59 DeferredTaxAndRevenue is ₹0 Mil as of Mar. 2025. GuruFocus rates NSE:ARISTO with a GF Score™ of 59/100.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Aristo Bio-Tech and Lifescience's current deferred tax and revenue for the quarter that ended in Mar. 2025 was ₹0 Mil.

Aristo Bio-Tech and Lifescience DeferredTaxAndRevenue Related Terms

Aristo Bio-Tech and Lifescience DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Aristo Bio-Tech and Lifescience's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aristo Bio-Tech and Lifescience DeferredTaxAndRevenue Chart

Aristo Bio-Tech and Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
DeferredTaxAndRevenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Aristo Bio-Tech and Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:ARISTO
59GF Score
Aristo Bio-Tech and Lifescience Ltd NSE:ARISTO
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of ₹0 Mil mean?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a DeferredTaxAndRevenue of ₹0 Mil as of Mar. 2025. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Aristo Bio-Tech and Lifescience.
Is Aristo Bio-Tech and Lifescience's DeferredTaxAndRevenue too high?
Aristo Bio-Tech and Lifescience's current DeferredTaxAndRevenue is ₹0 Mil. Overall, Aristo Bio-Tech and Lifescience has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Aristo Bio-Tech and Lifescience's DeferredTaxAndRevenue compare to CTVA and CF?
Aristo Bio-Tech and Lifescience's DeferredTaxAndRevenue of ₹0 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for an Agriculture company?
A good DeferredTaxAndRevenue depends on the Agriculture industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Aristo Bio-Tech and Lifescience. Aristo Bio-Tech and Lifescience's current DeferredTaxAndRevenue is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aristo Bio-Tech and Lifescience stock overvalued right now?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a current DeferredTaxAndRevenue of ₹0 Mil. The current DeferredTaxAndRevenue is ₹0 Mil. Aristo Bio-Tech and Lifescience's overall GF Score™ is 59/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Aristo Bio-Tech and Lifescience (NSE:ARISTO), the current DeferredTaxAndRevenue is ₹0 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aristo Bio-Tech and Lifescience Business Description

Address E-24, 25, 26, G.I.D.C, Manjusar, Taluka Savli, Vadodara, GJ, IND, 391775
Aristo Bio-Tech and Lifescience Ltd is an agrochemical company. It is mainly engaged in the manufacturing, formulation, supplying, packaging and job work services of various pesticides. The company exports products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators and a wide variety of other Agrochemicals.
59GF Score

Get the complete analysis for NSE:ARISTO

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹109.30
Price